| Dr Lee M Nicols, MD | |
|
1190 N State St, Suite 502, Jackson, MS 39202-2413 | |
| (601) 944-1781 | |
| (601) 353-0439 |
| Full Name | Dr Lee M Nicols |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 15 Years |
| Location | 1190 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750583415 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | T-1706 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sta Home Health And Hospice | Clinton, MS | Home health agency |
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| Copiah County Medical Center | Hazlehurst, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Surgical Associates | 1355359506 | 12 |
News Archive
As a cell moves forward, physical stress on its skeleton triggers molecular fingers and arms to grasp each other in reinforcing links that stabilize the skeleton, according to images produced by investigators at St. Jude Children's Research Hospital.
Strativa Pharmaceuticals today announced that it has entered into an amended and restated license and supply agreement with Swedish Orphan Biovitrum (Sobi) covering the European development and commercialization rights of Strativa's Nascobal (cyanocobalamin) Vitamin B12 Nasal Spray. Strativa acquired the worldwide rights to Nascobal from QOL Medical, LLC in March 2009, which included a pre-existing agreement with Sobi.
Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division.
Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".
The Enterprise Center at Salem State College today announced that three companies have been named as finalists in the North of Boston Business Plan competition. The finalists include companies that provide online local advertising, environmentally responsible household products and a solar energy business.
› Verified 3 days ago
| Entity Name | Central Surgical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639295009 PECOS PAC ID: 1355359506 Enrollment ID: O20060329000399 |
News Archive
As a cell moves forward, physical stress on its skeleton triggers molecular fingers and arms to grasp each other in reinforcing links that stabilize the skeleton, according to images produced by investigators at St. Jude Children's Research Hospital.
Strativa Pharmaceuticals today announced that it has entered into an amended and restated license and supply agreement with Swedish Orphan Biovitrum (Sobi) covering the European development and commercialization rights of Strativa's Nascobal (cyanocobalamin) Vitamin B12 Nasal Spray. Strativa acquired the worldwide rights to Nascobal from QOL Medical, LLC in March 2009, which included a pre-existing agreement with Sobi.
Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division.
Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".
The Enterprise Center at Salem State College today announced that three companies have been named as finalists in the North of Boston Business Plan competition. The finalists include companies that provide online local advertising, environmentally responsible household products and a solar energy business.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lee M Nicols, MD 1190 N State St, Suite 502, Jackson, MS 39202-2413 Ph: (601) 944-1781 | Dr Lee M Nicols, MD 1190 N State St, Suite 502, Jackson, MS 39202-2413 Ph: (601) 944-1781 |
News Archive
As a cell moves forward, physical stress on its skeleton triggers molecular fingers and arms to grasp each other in reinforcing links that stabilize the skeleton, according to images produced by investigators at St. Jude Children's Research Hospital.
Strativa Pharmaceuticals today announced that it has entered into an amended and restated license and supply agreement with Swedish Orphan Biovitrum (Sobi) covering the European development and commercialization rights of Strativa's Nascobal (cyanocobalamin) Vitamin B12 Nasal Spray. Strativa acquired the worldwide rights to Nascobal from QOL Medical, LLC in March 2009, which included a pre-existing agreement with Sobi.
Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division.
Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".
The Enterprise Center at Salem State College today announced that three companies have been named as finalists in the North of Boston Business Plan competition. The finalists include companies that provide online local advertising, environmentally responsible household products and a solar energy business.
› Verified 3 days ago
Dr. Wayne Shannon Orr Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5452 Fax: 601-815-3322 | |
Jacob M Folse, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5153 Fax: 601-984-6962 | |
Robert Eugene Schmieg Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 Fax: 601-926-4978 | |
Dr. Hal Gregory Fiser, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1190 N State St, Suite 502, Jackson, MS 39202 Phone: 601-944-1781 Fax: 601-353-0439 | |
Pierre Edouard De Delva, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, University Of Mississippi Medical Center, Jackson, MS 39216 Phone: 601-984-5170 | |
Dr. John Magruder Sullivan Iii, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 | |
Colton Lott, Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-1292 Fax: 601-984-5110 |